[Buprenorphine (Subutex) and neonatal withdrawal syndrome].
Hervé
F
F
Quenum
S
S
D000701:Analgesics, Opioid / Q000009:adverse effects* / Q000627:therapeutic use; D000930:Antidiarrheals / Q000627:therapeutic use; D002047:Buprenorphine / Q000009:adverse effects* / Q000627:therapeutic use; D003681:Dehydration / Q000139:chemically induced / Q000188:drug therapy; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D008431:Maternal-Fetal Exchange; D009892:Opium / Q000627:therapeutic use; D011247:Pregnancy; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy
D000701:Analgesics, Opioid; D000930:Antidiarrheals; D002047:Buprenorphine; D009892:Opium; C017652:paregoric